Showing 1 - 4 results of 4 for search 'Colin A Flaveny', query time: 0.03s Refine Results
  1. 1
    Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice.

    Rev-erbα heterozygosity produces a dose-dependent phenotypic advantage in mice. by Ryan D Welch, Cyrielle Billon, Amina Kameric, Thomas P Burris, Colin A Flaveny

    Published 2020-01-01
    Get full text
    Article
  2. 2
    The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis

    The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis by Kristine Griffett, Ryan D. Welch, Colin A. Flaveny, Grant R. Kolar, Brent A. Neuschwander-Tetri, Thomas P. Burris

    Published 2015-04-01
    Get full text
    Article
  3. 3
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.

    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis. by Monideepa Sengupta, Suomia Abuirqeba, Amina Kameric, Aurore Cecile-Valfort, Arindam Chatterjee, Kristine Griffett, Thomas P Burris, Colin A Flaveny

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.

    Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis. by Bin Li, Colin A Flaveny, Camilla Giambelli, Dennis Liang Fei, Lu Han, Brian I Hang, Feng Bai, Xin-Hai Pei, Vania Nose, Oname Burlingame, Anthony J Capobianco, Darren Orton, Ethan Lee, David J Robbins

    Published 2014-01-01
    Get full text
    Article

Search Tools: